CLINICAL STUDIES at MGH

1. Fatty liver disease with fibrosis and inflammation. Long term study (18+ months)with oral medication, called Obeticholic Acid. Enrolling now, call 415 3532012 (Nora is the coordinator) or 6415430 (Dr Bonacini). A liver biopsy is needed to enter the study.

2. NASH with stages 3 or 4 Fibrosis: Oral medication (Selonsertib) for 18+ months. Liver biopsy needed to enter the study.

 3. Fatty liver disease with fibrosis and inflammation. SHORT  term study (16 weeks total) with oral  medication, which improves fibrosis and fat content in the liver. Enrolling now, call 415 3532012 (Nora is the coordinator) or 6415430 (Dr Bonacini). A liver biopsy is NOT needed to enter the study